Original Research
Published on 03 Aug 2021
Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
in Cancer Molecular Targets and Therapeutics
- 3,437 views
- 12 citations